Latest stock market news videos & Morning Bell

Interview SeriesMarket WrapsInsights
Interview Series

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

Bell Direct
March 20, 2026

In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive disease affecting involuntary functions and motor control.

Insights

XTB’s Concentrated High Yield & Maturity Ladder portfolios

Bell Direct
October 27, 2017
Insights

Corporate bonds and low rate environment

Bell Direct
October 27, 2017
Market Wraps

Weely Wrap 6 October

Bell Direct
October 6, 2017
Insights

The PEAD impact on the market in September

Bell Direct
September 28, 2017
Market Wraps

Weekly Wrap 8 September

Bell Direct
September 8, 2017
Market Wraps

What we saw this reporting season

Bell Direct
August 29, 2017
Market Wraps

Weekly Wrap 25 August

Bell Direct
August 25, 2017
Market Wraps

Weekly Wrap 18 August

Bell Direct
August 18, 2017
Market Wraps

Market Update

Bell Direct
August 16, 2017
Market Wraps

Weekly Wrap 11 August

Bell Direct
August 11, 2017
Market Wraps

Weekly Wrap 4 August

Bell Direct
August 8, 2017
Insights

What to expect this reporting season

Bell Direct
July 25, 2017
  1. Pages:
  3. 1
  4. ...
  5. 155
  6. 156
  7. 157
  8. 158
  9. 159
  10. 160
  11. 161
  12. 162
  13. 163